Search

everythinglearnresearchcommunity

for

Search:↓

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

Cimetidine did not reduce hair growth in women with hirsutism.

Korean patients with PCOS often have skin problems like acne and excess hair, with different symptoms based on their specific PCOS type.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Lupus patients' body image issues significantly affect their mental health and need more support.

Southern Chinese women with female pattern hair loss have less, thinner hair and smaller hair follicles.

Dermoscopy is useful for many health professionals, not just dermatologists, in improving skin condition diagnoses and reducing unnecessary biopsies.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

Women with acne have lower levels of a specific hormone marker than women without acne.